The second amendment to the MDR/IVDR standardisation request M/575 has been adopted on 27 May 2024 as “COMMISSION IMPLEMENTING DECISION amending Implementing Decision C(2021) 2406 on a standardisation request to the European Committee for Standardization and the European Committee for Electrotechnical Standardization as regards medical devices in support of Regulation (EU) 2017/745 of the European Parliament and of the Council and in vitro diagnostic medical devices in support of Regulation (EU) 2017/746 of the European Parliament and of the Council, as regards the scope and validity of the request and the deadlines for the joint final report and for the adoption of certain harmonised standards, certain general requirements and the requirements for certain specific standards (C(2024)3371)”.
News & Trends
Procurar
Recentes
- Computer Software Assurance for Production and Quality Management System Software
- FDA CDER – 2025 New Drug Therapy Approvals: key takeaways
- The MDSAP Audit Approach (MDSAP AU P0002.010) was just revised
- FDA Clinical Decision Support Software
- FDA GUIDANCE : Cybersecurity in Medical Devices: Quality Management System Considerations and Content of Premarket Submissions
- The FDA’s updated compliance program manual
- The FDA’s Quality Management System Regulation (QMSR) is now LIVE and fully effective
- ICH M11 guideline, clinical study protocol template and technical specifications – Scientific guideline